Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 21

Publication Record

Connections

A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.
Laubach JP, Moslehi JJ, Francis SA, San Miguel JF, Sonneveld P, Orlowski RZ, Moreau P, RosiƱol L, Faber EA, Voorhees P, Mateos MV, Marquez L, Feng H, Desai A, van de Velde H, Elliott J, Shi H, Dow E, Jobanputra N, Esseltine DL, Niculescu L, Anderson KC, Lonial S, Richardson PG
(2017) Br J Haematol 178: 547-560
MeSH Terms: Antineoplastic Agents, Benchmarking, Bortezomib, Cardiovascular Diseases, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Dyspnea, Heart Failure, Humans, Multiple Myeloma, Proteasome Inhibitors, Retrospective Studies, Risk Factors
Added December 2, 2017
0 Communities
1 Members
0 Resources
13 MeSH Terms
Calcium/magnesium intake ratio, but not magnesium intake, interacts with genetic polymorphism in relation to colorectal neoplasia in a two-phase study.
Zhu X, Shrubsole MJ, Ness RM, Hibler EA, Cai Q, Long J, Chen Z, Li G, Jiang M, Hou L, Kabagambe EK, Zhang B, Smalley WE, Edwards TL, Giovannucci EL, Zheng W, Dai Q
(2016) Mol Carcinog 55: 1449-57
MeSH Terms: Adult, Aged, Calcium, Dietary, Clinical Trials, Phase I as Topic, Clinical Trials, Phase II as Topic, Colorectal Neoplasms, Female, Humans, Magnesium, Male, Middle Aged, Parathyroid Hormone, Polymorphism, Single Nucleotide, Protein Serine-Threonine Kinases, TRPM Cation Channels
Added September 28, 2015
0 Communities
7 Members
0 Resources
15 MeSH Terms
Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma.
Johnson DB, Puzanov I, Kelley MC
(2015) Immunotherapy 7: 611-9
MeSH Terms: Animals, Clinical Trials, Phase II as Topic, Herpesviridae, Humans, Melanoma, Oncolytic Virotherapy, Oncolytic Viruses
Added February 16, 2016
0 Communities
1 Members
0 Resources
7 MeSH Terms
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.
Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE
(2014) J Clin Oncol 32: 1277-80
MeSH Terms: Clinical Trials as Topic, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Humans, Medical Oncology, Societies, Medical, Treatment Outcome, United States
Added March 20, 2014
0 Communities
1 Members
0 Resources
8 MeSH Terms
Improving diagnostic capability for HPV disease internationally within the NIH-NIAID Division of AIDS Clinical Trial Networks.
Godfrey CC, Michelow PM, Godard M, Sahasrabuddhe VV, Darden J, Firnhaber CS, Wetherall NT, Bremer J, Coombs RW, Wilkin T, A5282 Study Team
(2013) Am J Clin Pathol 140: 881-9
MeSH Terms: Acquired Immunodeficiency Syndrome, Clinical Trials, Phase II as Topic, Female, Human Papillomavirus DNA Tests, Humans, Laboratories, Mass Screening, National Institutes of Health (U.S.), Papillomavirus Infections, Pathology, Quality Assurance, Health Care, Randomized Controlled Trials as Topic, United States, Uterine Cervical Neoplasms
Added March 5, 2014
0 Communities
1 Members
0 Resources
14 MeSH Terms
Targeting angiogenesis in advanced non-small cell lung cancer.
Lammers PE, Horn L
(2013) J Natl Compr Canc Netw 11: 1235-47
MeSH Terms: Angiogenesis Inhibitors, Antineoplastic Agents, Biomarkers, Carcinoma, Non-Small-Cell Lung, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Humans, Lung Neoplasms, Neoplasm Staging, Neovascularization, Pathologic, Prognosis, Treatment Outcome
Added June 26, 2014
0 Communities
1 Members
0 Resources
12 MeSH Terms
Aflibercept.
Ciombor KK, Berlin J, Chan E
(2013) Clin Cancer Res 19: 1920-5
MeSH Terms: Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Colorectal Neoplasms, Disease-Free Survival, Fluorouracil, Humans, Irinotecan, Leucovorin, Neoplasm Metastasis, Organoplatinum Compounds, Oxaliplatin, Placenta Growth Factor, Pregnancy Proteins, Protein Binding, Randomized Controlled Trials as Topic, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Treatment Outcome, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor B
Added September 10, 2013
0 Communities
4 Members
0 Resources
22 MeSH Terms
EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib.
Chmielecki J, Pietanza MC, Aftab D, Shen R, Zhao Z, Chen X, Hutchinson K, Viale A, Kris MG, Stout T, Miller V, Rizvi N, Pao W
(2012) J Thorac Oncol 7: 434-42
MeSH Terms: Adenocarcinoma, Antineoplastic Combined Chemotherapy Protocols, Azabicyclo Compounds, Biomarkers, Tumor, Clinical Trials, Phase II as Topic, Drug Resistance, Neoplasm, ErbB Receptors, Erlotinib Hydrochloride, Gene Expression Profiling, Humans, Immunoblotting, In Situ Hybridization, Fluorescence, Lung Neoplasms, Mutation, Neoplasm Staging, Oligonucleotide Array Sequence Analysis, Prognosis, Protein Kinase Inhibitors, Quinazolines, Small Cell Lung Carcinoma, Tumor Cells, Cultured
Added September 3, 2013
0 Communities
2 Members
0 Resources
21 MeSH Terms
Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women.
Dorjgochoo T, Delahanty R, Lu W, Long J, Cai Q, Zheng Y, Gu K, Gao YT, Zheng W, Shu XO
(2011) Cancer Epidemiol Biomarkers Prev 20: 2313-6
MeSH Terms: Adult, Aged, Breast Neoplasms, Case-Control Studies, China, Clinical Trials, Phase I as Topic, Clinical Trials, Phase II as Topic, Female, Follow-Up Studies, Genome-Wide Association Study, Humans, Middle Aged, Polymorphism, Single Nucleotide, Prognosis, Receptors, Calcitriol, Risk Factors, Signal Transduction, Steroid Hydroxylases, Vitamin D, Vitamin D3 24-Hydroxylase
Added December 10, 2013
0 Communities
2 Members
0 Resources
20 MeSH Terms
Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib.
Richards CJ, Je Y, Schutz FA, Heng DY, Dallabrida SM, Moslehi JJ, Choueiri TK
(2011) J Clin Oncol 29: 3450-6
MeSH Terms: Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Carcinoma, Renal Cell, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Follow-Up Studies, Heart Failure, Humans, Incidence, Indoles, Kidney Neoplasms, Middle Aged, Pyrroles, Randomized Controlled Trials as Topic, Risk Factors, Sunitinib, Survival Rate, Treatment Outcome
Added March 4, 2015
0 Communities
1 Members
0 Resources
20 MeSH Terms